focus -WSS

focus

author：fashion 2025-10-04 11:35:29 - browse：699

Vials and packaging for Leqembi, a new Alzheimer's medication approved in the U.S., but not yet in Europe. Illustration: Alex Hogan/STAT; Photo: Eisai via AP

LONDON — Starting Sunday, Alzheimer’s specialists will gather for a major conference in Amsterdam, convening at a time when the field, depending on which expert you ask, has some rare momentum behind it, with new therapies starting to show benefits for patients.

But despite the hard-won victories, the arrival of the new therapies presents a new set of challenges in Europe as countries plan for their possible rollouts, scientists and doctors told STAT.

Health systems will have to adapt to diagnose people earlier and monitor them for side effects associated with the treatments. If their medicines win European approval, companies will have to strike reimbursement deals in all member states, a process that often leaves some countries waiting years for new drugs to become available. The hurdles mean the therapies will likely be offered only at certain centers initially, constraining how many patients have access to them, doctors from across Europe said.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： 7 people shot in DC, police say

entertainment

WSS

3 dead in firefighting helicopter crash in California after midair collision with 2nd helicopter

Israel demolishes home of alleged Palestinian attacker, fueling West Bank tensions

Grail is spending more than ever lobbying Congress

Democratic lawmaker calls for 'well

Why is France rioting? What to know about the fatal police shooting of Nahel M

Russia says it foiled Ukrainian drone attack on Moscow as Kyiv's counteroffensive grinds on

hotspot

focus

Wikipedia

In Memoriam: Notable people who died in 2023

In medicine, common shorthands can shortchange care

Heart attack and stroke risk calculators need revising

Doctor appointment wait times are getting worse

United colonoscopy coverage change 'may cost lives,' doctors say

NYC plans to house migrants on an island in the East River

Moonlake's readout produced a cash windfall. Risks remain

The UK government moves asylum

New air purifier tech could be key to improving indoor air quality

Pfizer's Covid pill remains 89% effective in final analysis, company says

focus

Community addresses injustice for Long Island mothers

More people are opting for early dinners since the pandemic, says OpenTable CEO Debby Soo

Bursting ice dam in Alaska highlights risks of glacial flooding around the globe

Boeing's 1st astronaut flight bumped into next year, more repairs needed

Australia's humpback populations rebound raising hopes of marine scientists

3 dead in firefighting helicopter crash in California after midair collision with 2nd helicopter

focus

entertainment

entertainment

knowledge